Otoprotectant for Aminoglycoside-Induced Hearing Loss

About Ting Therapeutics

Ting Therapeutics is a private, pre-clinical stage biotech developing novel therapeutics to prevent chemotherapy-induced hearing loss. Founded by academic researchers, the company is repurposing and adapting oncology drugs to protect auditory function without interfering with antibiotic efficacy. It operates in a high-need, underserved market with no FDA-approved protective agents, positioning its lead candidates for significant impact if clinical development is successful.

Therapeutic Areas